货号:A1477298
同义名:
2-巯基吡啶-N-氧化物 锌盐;吡硫锌
/ OM-1563
Zinc pyrithione是一种具有抗真菌和抗细菌活性的药物,可以通过阻断质子泵(Proton pump)破坏膜转运。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 靶点 |
|
| 描述 | Zinc Pyrithione is an antifungal and antibacterial agent by disrupting membrane transport through blocking the proton pump[1]. Zinc Pyrithione is also a copper ionophore, facilitating the transport of copper ions into cells, which is beneficial for studying cuproptosis[2]. |
| 体外研究 | Zinc Pyrithione is a coordination complex where the pyrithione ligands, formally monoanions, chelate to zinc ions (Zn 2+) via oxygen and sulfur centers. In its crystalline form, it forms a centrosymmetric dimer, with each zinc ion bonded to two sulfur and three oxygen centers. In solution, these dimers can dissociate by breaking one Zn-O bond. As a dimer, Zinc Pyrithione is likely biologically active in its monomer form and is known to induce plasma membrane depolarization, with a half-maximal effective concentration (K1/2) of approximately 0.3 mM[1]. Zinc Pyrithione, at concentrations ranging from 10 nM to 10 μM over a period of 72 hours, significantly promotes cell death in AAVS1 cells[2]. |
| Concentration | Treated Time | Description | References | |
| Human lung tissue (HLT) cells | 30, 10, 1, 0.5 µM | 1 hour | Evaluation of zinc pyrithione's inhibitory effect on SARS-CoV-2 entry, showing 93.12% inhibition at 30 μM concentration. | J Enzyme Inhib Med Chem. 2022 Dec;37(1):2158-2168. |
| DRG neurons | 1 µM | 20 seconds | ZnPy induces Ca2+ responses via TRPA1 | Proc Natl Acad Sci U S A. 2009 May 19;106(20):8374-9. |
| T98GN cancer cells | 10 µM | 2 hours | Measured intracellular zinc levels, showing ZP significantly increased intracellular Zn | Cell Syst. 2017 Jun 28;4(6):600-610.e6. |
| A549N cancer cells | 10 µM | 2 hours | Measured intracellular zinc levels, showing ZP significantly increased intracellular Zn | Cell Syst. 2017 Jun 28;4(6):600-610.e6. |
| Streptococcus dysgalactiae | 0.031 µg/mL | 24 hours | Evaluate the synergistic antibacterial effect of zinc pyrithione with gentamicin, showing strong synergy | Antibiotics (Basel). 2022 Jul 17;11(7):960. |
| Streptococcus agalactiae | 0.031 µg/mL | 24 hours | Evaluate the synergistic antibacterial effect of zinc pyrithione with gentamicin, showing strong synergy | Antibiotics (Basel). 2022 Jul 17;11(7):960. |
| Staphylococcus aureus | 0.25 µg/mL | 24 hours | Evaluate the synergistic antibacterial effect of zinc pyrithione with gentamicin, showing high susceptibility in some strains | Antibiotics (Basel). 2022 Jul 17;11(7):960. |
| HSC2 cells | 0.5 µM to 2 µM | 48 hours | PYZ treatment led to 52.7% cells in sub-G0 phase and significantly increased apoptosis (from 21.6% to 88.8%). | Mol Oncol. 2015 Oct;9(8):1720-35. |
| MDA1986 cells | 0.5 µM to 2 µM | 48 hours | PYZ treatment resulted in 85.7% cells in sub-G0 phase and markedly induced apoptosis (increased from 16.9% to 93.6%). | Mol Oncol. 2015 Oct;9(8):1720-35. |
| SCC4 cells | 0.5 µM to 2 µM | 48 hours | PYZ treatment induced cell cycle arrest and apoptosis, significantly increasing sub-G0 fraction (65.6%) and activating cleavage of caspase 3, caspase 9, and PARP. | Mol Oncol. 2015 Oct;9(8):1720-35. |
| M10 cells | 0.5 µM | 72 hours | To evaluate the effect of zinc pyrithione on the proliferation, intracellular free zinc content, and autophagic activity of M10 cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels, inhibited cell proliferation, and enhanced autophagic activity over 72 hours. | Int J Mol Sci. 2021 Jan 11;22(2):667. |
| M9 cells | 0.5 µM | 72 hours | To evaluate the effect of zinc pyrithione on the proliferation, intracellular free zinc content, and autophagic activity of M9 cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels, strongly inhibited cell proliferation, and significantly enhanced autophagic activity over 72 hours. | Int J Mol Sci. 2021 Jan 11;22(2):667. |
| M5 cells | 0.5 µM | 72 hours | To evaluate the effect of zinc pyrithione on the proliferation, intracellular free zinc content, and autophagic activity of M5 cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels, inhibited cell proliferation, and enhanced autophagic activity over 72 hours. | Int J Mol Sci. 2021 Jan 11;22(2):667. |
| HEM cells | 0.5 µM | 72 hours | To evaluate the effect of zinc pyrithione on the proliferation and intracellular free zinc content of HEM cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels but had a weaker inhibitory effect on cell proliferation over 72 hours. | Int J Mol Sci. 2021 Jan 11;22(2):667. |
| Bowes cells | 0.5 µM | 72 hours | To evaluate the effect of zinc pyrithione on the proliferation and intracellular free zinc content of Bowes cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels and inhibited cell proliferation over 72 hours. | Int J Mol Sci. 2021 Jan 11;22(2):667. |
| FHs 74 Int (normal intestinal cells) | 0.3 µg/mL | 72 hours | Evaluate the cytotoxicity of zinc pyrithione on normal intestinal cells, showing some toxicity to normal cells. | Pharmaceuticals (Basel). 2020 Sep 3;13(9):233. |
| Caco-2 (intestinal cancer cells) | 0.7 µg/mL | 72 hours | Evaluate the antiproliferative activity of zinc pyrithione on Caco-2 intestinal cancer cells, showing significant cytotoxicity. | Pharmaceuticals (Basel). 2020 Sep 3;13(9):233. |
| HT29 (intestinal cancer cells) | 0.6 µg/mL | 72 hours | Evaluate the antiproliferative activity of zinc pyrithione on HT29 intestinal cancer cells, showing significant cytotoxicity. | Pharmaceuticals (Basel). 2020 Sep 3;13(9):233. |
| CHO cells | 2.4 µM (EC50) | ZnPy activates TRPA1 by increasing intracellular Zn2+ concentration | Proc Natl Acad Sci U S A. 2009 May 19;106(20):8374-9. | |
| CHO cells | 10 µM | Study the effect of ZnPy on KCNQ3 channels, showing no response to ZnPy. | Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3128-33. | |
| CHO cells | 10 µM | Investigate the potentiating effect of ZnPy on KCNQ2 channels, showing significant increase in current amplitude. | Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3128-33. | |
| Hippocampal neurons | 10 µM | To study the inhibitory effect of ZnPy on neuronal firing after muscarinic receptor activation. Results showed that ZnPy completely abolished Oxo-M-induced spontaneous firing, whereas retigabine only partially inhibited it. | Proc Natl Acad Sci U S A. 2013 May 21;110(21):8726-31. | |
| CHO cells | 10 µM | To investigate the augmentation effect of ZnPy on KCNQ2 currents after M1 receptor activation. Results showed that ZnPy immediately augmented the Oxo-M suppressed KCNQ2 current, and the effect was reversible. | Proc Natl Acad Sci U S A. 2013 May 21;110(21):8726-31. | |
| Administration | Dosage | Frequency | Description | References | ||
| NOD/SCID/Crl mice | SCC4 xenograft model | Intraperitoneal injection | 1 mg/kg | Weekly for 6 weeks | PYZ treatment significantly reduced tumor volume (mean 316.24 mm3 vs control 479.6 mm3) without apparent toxicity. β-catenin expression decreased (positive cells reduced from 67% to 8%). | Mol Oncol. 2015 Oct;9(8):1720-35. |
| Drosophila melanogaster | GNAO1 encephalopathy model | Dietary supplementation | 10 µM | Continuous supplementation starting from the egg stage | To test the effect of dietary zinc supplementation on the motor function and lifespan of Drosophila, results showed that ZnCl2 significantly improved the motor function and lifespan of mutant flies. | Sci Adv. 2022 Oct 7;8(40):eabn9350 |
| Human skin | Human abdominal skin | Topical application | 2% w/v | 24 hours | To assess the delivery and dissolution of zinc pyrithione in hair follicles | Pharmaceutics. 2022 May 17;14(5):1076 |
| Mice | TRPA1-deficient mice | Intraplantar injection | 2.5 nmoles | Single injection, observed for 4 hours | CQ induces mechanical hyperalgesia and cold hypersensitivity via TRPA1 | Proc Natl Acad Sci U S A. 2009 May 19;106(20):8374-9. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.15mL 0.63mL 0.31mL |
15.74mL 3.15mL 1.57mL |
31.47mL 6.29mL 3.15mL |
|
| CAS号 | 13463-41-7 |
| 分子式 | C10H8N2O2S2Zn |
| 分子量 | 317.72 |
| SMILES Code | [O-][N+]1=C(C=CC=C1)S[Zn]SC2=[N+]([O-])C=CC=C2 |
| MDL No. | MFCD00067336 |
| 别名 | 2-巯基吡啶-N-氧化物 锌盐;吡硫锌;1-羟基吡啶-2-硫酮锌 ;OM-1563 |
| 运输 | 蓝冰 |
| InChI Key | OTPSWLRZXRHDNX-UHFFFAOYSA-L |
| Pubchem ID | 26041 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 35 mg/mL(110.16 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1